Trial Profile
Phase II study of IPI 940 in patients with pain
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jan 2011
Price :
$35
*
At a glance
- Drugs IPI 940 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Purdue Pharma
- 10 Jan 2011 New trial record
- 07 Jan 2011 Infinity Pharmaceuticals expect to complete transition activities to facilitate phase II studies in pain by Purdue Pharmaceuticals, according to an Infinity media release